Literature DB >> 30241046

PIG11 over-expression predicts good prognosis and induces HepG2 cell apoptosis via reactive oxygen species-dependent mitochondrial pathway.

Yan Wang1, Xiaomin Liu2, Gang Liu3, Xiaojuan Wang2, Rong Hu2, Xiaoqiu Liang4.   

Abstract

P53-induced protein 11 (PIG11), one of the primeval transcriptional targets of p53, is up-regulated in apoptosis induced by multiple chemopreventive agents and is involved in tumorigenesis or tumor development. Nevertheless, the clinical value and biological role of PIG11 in hepatocellular carcinoma (HCC) are still unknown. In the present article, we explored the expression pattern of PIG11 in HCC tumor tissues, the prognostic value of PIG11 for HCC patients, and the biological functions on the apoptosis of HepG2 cells. We discovered that high PIG11 expression was negatively associated with certain clinical characteristics, and higher expression of PIG11 resulted in better prognosis of patients with HCC. PIG11 over-expression induced HepG2 cell apoptosis through the mitochondrial pathway, and reactive oxygen species played a regulatory role in this process. Hence, PIG11 may act as a candidate liver tumor suppressor and exhibit potential as a novel prognostic biomarker for HCC.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Apoptosis; HepG2 cell; Hepatocellular carcinoma (HCC); Mitochondria; PIG11; Reactive oxygen species (ROS)

Mesh:

Substances:

Year:  2018        PMID: 30241046     DOI: 10.1016/j.biopha.2018.09.062

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  2 in total

1.  High expression of PIG11 correlates with poor prognosis in gastric cancer.

Authors:  Juan Gu; Shu Zhang; Xin He; Sufang Chen; Yan Wang
Journal:  Exp Ther Med       Date:  2021-01-22       Impact factor: 2.447

2.  FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma.

Authors:  Yan Wang; Mengjing Sun; Jibin Liu; Ying Liu; Chunyi Jiang; Huijun Zhu; Wei Wang; Yao Wang
Journal:  Oncol Lett       Date:  2019-12-04       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.